scholarly journals Discussing alcohol in medicines use reviews: experiences of patients in a community pharmacy context

2018 ◽  
Vol 27 (3) ◽  
pp. 318-321 ◽  
Author(s):  
Kimberly Jamie ◽  
Emily J. Oliver ◽  
Alistair Paterson ◽  
Cate Whittlesea
2019 ◽  
Vol 1 (3) ◽  
pp. 146-148
Author(s):  
Rosemary Adsley

Medication review services are an important part of the advanced services provided by community pharmacists. The aim of these services, medicines use reviews (MURs) and the new medicines service (NMS) are to identify issues patients may encounter with long term medications, support patients with adherence to new medications and to communicate issues to prescribers. By working together to improve awareness and access to these services, it is hoped that health professionals can improve adherence and reduce medication waste.


2010 ◽  
Vol 71 (3) ◽  
pp. 451-458 ◽  
Author(s):  
Ruth McDonald ◽  
Sudeh Cheraghi-Sohi ◽  
Caroline Sanders ◽  
Darren Ashcroft

2020 ◽  
Vol 105 (9) ◽  
pp. e1.1-e1
Author(s):  
Rebecca Venables ◽  
Eirini Iliopoulou ◽  
Tania Cork

AimTo evaluate Medicines Use Reviews (MURs) in community pharmacies, with a focus on MURs conducted with children alone and with their guardian(s).MethodA service evaluation of MURs was conducted using a questionnaire proforma. The questionnaire proforma design was informed by current literature and MUR guidance (PSNC)1 and included both quantitative and qualitative questions in order to understand how pharmacists approach and perceive conducting MURs, with a specific focus on those with children alone and with their guardian(s). Participants were community pharmacists holding an MUR accreditation by a Higher Education Institution, whom had already performed at least one MUR. Quantitative data formed descriptive statistics and this was supported by the qualitative data which was analysed using a thematic framework approach. Ethics was not required; this work was a service evaluation.ResultsIn total, 16 community pharmacists participated. The majority 81% (13/16) reported that they did not conduct any MURs in patients younger than 18 years. All participants reported feeling confident when conducting MURs in adults; whilst 56% (9/16) of participants reported feeling confident in conducting an MUR with a child with their parent/guardian present and only 25% (4/16) feeling confident with a child alone. Lack of confidence regarding child MURs was linked to paucity of opportunity, insufficient experience and training, and the need to amend question technique. Regarding consent, 75% (12/16) of participants reported that they were not confident in taking MUR consent from children, and 31% (5/16) from adolescents. Reasons for low confidence in gaining child/adolescent consent included never conducting MURs in children - so no experience in gaining consent, concern regarding child understanding, and always wanting a responsible adult present. Further barriers to MURs in children included: issues surrounding safeguarding, children possibly not having the necessary knowledge to participate if parents are responsible for medicines management, child ability to provide full consent and child anxiety, thus impact on aptitude to communicate effectively.ConclusionThis was a small-scale evaluation exploring MURs in children. Supporting anecdotal evidence prior to this study, study findings suggest that very few MURs are conducted in patients less than 18 years. Community pharmacists discussed poorer confidence in conducting MURs with children and adolescents compared to adults. Reports highlighted that the major barriers to conducting MURs in this patient cohort may be related to pharmacists’ concerns surrounding child consent and potential lack of experience and training. This study should be used to inform larger studies exploring barriers to gaining consent in children, and also conducting appropriate services with children. Analogous studies with other healthcare professional groups would be beneficial, and this data could be compared. Findings should also help to shape future education and training for pharmacists and allied healthcare professionals in order to optimise future patient services, thus patient care.ReferencePSNC. 2018. MURs: the basics. [online] Available at: https://psnc.org.uk/servicescommissioning/advanced-services/murs/murs-the-basics/ [Accessed 19 Nov. 2018]


2018 ◽  
Vol 103 (2) ◽  
pp. e2.49-e2
Author(s):  
Jeff Aston

AimTo identify the experiences of community pharmacists in caring for children/young people, or their parents/carers, taking long-term medicines.MethodA pre-piloted 13 point semi-structured survey, participant information leaflet, consent form and pre-paid return envelope were posted to all 354 community pharmacists who had dispensed a prescription from a single specialist paediatric hospital during November and December 2015. Community pharmacy addresses were obtained from the National Health Service Business Services Authority ePACT system. Telephone follow-up of non-responders and, if necessary, a repeat mailing was made from 3 weeks after the original return by date.Participants were asked about their experiences of undertaking a medication review with either children/young people or their parents/carers, medication-related problems presenting to them, adherence, information needs of patients/carers and what issues were reported to them from this group.The data were analysed using SPSS version 22 and NVivo version 10.ResultsA response rate of 76/354 (21.5%) was achieved. Eighteen (23.7%) respondents had undertaken a Medicines Use Review (MUR),122 (28.9%) a New Medicines Service (NMS)2 review and 16 (21.1%) had undertaken another type of medication review in a child/young person. Respondents reported that patients or their carers had presented to them with adherence issues including stopping the medicine (24, 31.6%) and changing the dose (28, 36.8%) without informing the prescriber. Patients or their carers had requested information from them about the indication (59, 77.6%), dose regime (63, 82.9%), administration (64, 84.2%) and adverse effects (58, 76.6%). Respondents also reported patients/carers experiencing difficulties obtaining further supplies of a medicine from their community pharmacy (47, 61.8%) and patients’ general practitioners declining to prescribe a medicine recommended by the patient’s hospital-based specialist (27, 35.5%).ConclusionThis study has demonstrated that children, and their carers, taking long-term medicines experience a range of issues that they present to community pharmacists. Many of these issues would fall within the purview of currently funded medication review services namely the NMS and MUR.1,2 However, the proportion of pharmacists in this study undertaking formal medication review with children or their parents/carers was low. Further work is required to demonstrate the outcomes that such a review could have in this cohort of patients.ReferencesPharmaceutical Services Negotiating Committee. MURs: The basics. What is the medicines use review and prescription intervention service? [Internet] 2016. Available from: MURs: The basics http://psnc.org.uk/services-commissioning/advanced-services/murs/murs-the-basics/ [Available: 19 May 2016].Pharmaceutical Services Negotiating Committee. New Medicines Service (NMS) [Internet] 2016. http://psnc.org.uk/services-commissioning/advanced-services/nms/ [Available: 19 May 2016].


Health Policy ◽  
2008 ◽  
Vol 88 (2-3) ◽  
pp. 258-268 ◽  
Author(s):  
Fay Bradley ◽  
Andrew C. Wagner ◽  
Rebecca Elvey ◽  
Peter R. Noyce ◽  
Darren M. Ashcroft

Sign in / Sign up

Export Citation Format

Share Document